Cargando…

Characterization of Individuals Interested in Participating in a Phase I SARS-CoV-2 Vaccine Trial

The development of an effective vaccine against SARS-CoV-2 marks one of the highest priorities during the ongoing pandemic. However, recruitment of participants for clinical trials can be challenging, and recruitment failure is among the most common reasons for discontinuation in clinical trials. Fr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shamsrizi, Parichehr, Kramer, Frederik Johannes, Addo, Marylyn Martina, Fathi, Anahita
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8538230/ https://www.ncbi.nlm.nih.gov/pubmed/34696316 http://dx.doi.org/10.3390/vaccines9101208

Ejemplares similares

Correlates of Vaccine-Induced Protection against SARS-CoV-2
por: Koch, Till, et al.
Publicado: (2021)

Recombinant vesicular stomatitis virus vector vaccines for WHO blueprint priority pathogens
por: Fathi, Anahita, et al.
Publicado: (2019)

Sex Differences in Immunity: Implications for the Development of Novel Vaccines Against Emerging Pathogens
por: Fathi, Anahita, et al.
Publicado: (2021)

2343. SARS-CoV-2 Spike Conformation Essentially Influences Vaccine Immunogenicity – Results from Two Clinical Phase I Trials of the Vector Vaccine Candidates MVA-SARS-2-S and MVA-SARS-2-ST
por: Fathi, Anahita, et al.
Publicado: (2023)

Traveling into the Abyss: Risk Perception of German Travelers at the Onset of the COVID-19 Pandemic
por: Shamsrizi, Parichehr, et al.
Publicado: (2020)

Longitudinal monitoring of laboratory markers characterizes hospitalized and ambulatory COVID-19 patients
por: Velavan, Thirumalaisamy P., et al.
Publicado: (2021)

Humoral and Cellular Immune Response After Third and Fourth SARS-CoV-2 mRNA Vaccination in Liver Transplant Recipients
por: Harberts, Aenne, et al.
Publicado: (2022)

SARS-CoV2-specific Humoral and T-cell Immune Response After Second Vaccination in Liver Cirrhosis and Transplant Patients
por: Ruether, Darius F., et al.
Publicado: (2022)

A simple, sensitive, and low‐cost FACS assay for detecting antibodies against the native SARS‐CoV‐2 spike protein
por: Hambach, Julia, et al.
Publicado: (2021)

Natural killer cell‐mediated ADCC in SARS‐CoV‐2‐infected individuals and vaccine recipients
por: Hagemann, Kerri, et al.
Publicado: (2022)

Persistence of MERS-CoV-spike-specific B cells and antibodies after late third immunization with the MVA-MERS-S vaccine
por: Weskamm, Leonie M., et al.
Publicado: (2022)

β-Propiolactone (BPL)-inactivation of SARS-Co-V-2: In vitro validation with focus on saliva from COVID-19 patients for scent dog training
por: Pilchová, Veronika, et al.
Publicado: (2023)

Flow cytometric protocol to characterize human memory B cells directed against SARS-CoV-2 spike protein antigens
por: Weskamm, Leonie M., et al.
Publicado: (2022)

Scent dog identification of SARS-CoV-2 infections in different body fluids
por: Jendrny, Paula, et al.
Publicado: (2021)

Heatwaves and their health risks: knowledge, risk perceptions and behaviours of the German population in summer 2022
por: Shamsrizi, Parichehr, et al.
Publicado: (2023)

Viren überlisten: Globale Virusinfektionen werden beherrschbar – aber neue Gefahren drohen
por: Addo, Marylyn Martina, et al.
Publicado: (2016)

SARS‐CoV‐2 vaccination response in patients with autoimmune hepatitis and autoimmune cholestatic liver disease
por: Duengelhoef, Paul, et al.
Publicado: (2022)

Variation of effect estimates in the analysis of mortality and length of hospital stay in patients with infections caused by bacteria-producing extended-spectrum beta-lactamases: a systematic review and meta-analysis
por: Shamsrizi, Parichehr, et al.
Publicado: (2020)

Monkeypox Virus Cross-Neutralizing Antibodies in Clinical Trial Participants Vaccinated With Modified Vaccinia Virus Ankara Encoding Middle East Respiratory Syndrome–Coronavirus Spike Protein
por: Raadsen, Matthijs P, et al.
Publicado: (2023)

Digital PCR to quantify ChAdOx1 nCoV-19 copies in blood and tissues
por: Badbaran, Anita, et al.
Publicado: (2021)

Antimicrobial resistance rates in gram-positive bacteria do not drive glycopeptides use
por: Gladstone, Beryl Primrose, et al.
Publicado: (2017)

The significance of bioengineered nanoplatforms against SARS-CoV-2: From detection to genome editing
por: Hassanzadeh, Parichehr
Publicado: (2021)

Stabilized recombinant SARS-CoV-2 spike antigen enhances vaccine immunogenicity and protective capacity
por: Meyer zu Natrup, Christian, et al.
Publicado: (2022)

Discrimination of SARS-CoV-2 Infections From Other Viral Respiratory Infections by Scent Detection Dogs
por: ten Hagen, Nele Alexandra, et al.
Publicado: (2021)

Low SARS-CoV-2 infection rates and high vaccine-induced immunity among German healthcare workers at the end of the third wave of the COVID-19 pandemic
por: Brehm, Thomas Theo, et al.
Publicado: (2021)

Clinical Outcomes of SARS-CoV-2 Breakthrough Infections in Liver Transplant Recipients during the Omicron Wave
por: Herting, Anna, et al.
Publicado: (2023)

Addendum: competing interests and the origins of SARS-CoV-2
por: Editors of The Lancet
Publicado: (2021)

The Emerging Concern and Interest SARS-CoV-2 Variants
por: Janik, Edyta, et al.
Publicado: (2021)

Remdesivir-induced emergence of SARS-CoV2 variants in patients with prolonged infection
por: Heyer, Andreas, et al.
Publicado: (2022)

Three Separate Spike Antigen Exposures by COVID-19 Vaccination or SARS-CoV-2 Infection Elicit Strong Humoral Immune Responses in Healthcare Workers
por: Brehm, Thomas Theo, et al.
Publicado: (2022)

Phase I SARS vaccine trial in China
por: Orellana, Claudia
Publicado: (2004)

A phase 2/3 study of S-217622 in participants with SARS-CoV-2 infection (Phase 3 part)
por: Yotsuyanagi, Hiroshi, et al.
Publicado: (2023)

The Profession’s Interests above the Individual
Publicado: (1896)

Absence of self-reported neuropsychiatric and somatic symptoms after Omicron variant SARS-CoV-2 breakthrough infections
por: Woo, Marcel S, et al.
Publicado: (2023)

Microarray Profiling of Vaccination-Induced Antibody Responses to SARS-CoV-2 Variants of Interest and Concern
por: Svetlova, Julia, et al.
Publicado: (2022)

Efficacy of RTS,S malaria vaccines: individual-participant pooled analysis of phase 2 data
por: Bejon, Philip, et al.
Publicado: (2013)

SARS-CoV-2 specific cellular response following COVID-19 vaccination in patients with chronic lymphocytic leukemia
por: Mellinghoff, Sibylle C., et al.
Publicado: (2021)

Discovery and systematic assessment of early biomarkers that predict progression to severe COVID-19 disease
por: Hufnagel, Katrin, et al.
Publicado: (2023)

Current mutatome of SARS-CoV-2 in Turkey reveals mutations of interest
por: ESKİER, Doğa, et al.
Publicado: (2021)

Emergence and spread of two SARS-CoV-2 variants of interest in Nigeria
por: Olawoye, Idowu B., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_chh4sengsj5u7te23n84ljbbsb